evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/geneAliases/9,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
19770,GENE_BACKGROUND,,"The CYLD gene encodes a deubiquitinating enzyme. CYLD specifically removes lysine-63-linked ubiquitin marks. It negatively regulates NF-κB signaling by deubiquitinating upstream regulators such as TRAF2 and TRAF6 (PMID: 12917689, 12917691). CYLD has a tumor suppressor role, principally via NF-κB pathway inhibition and enhancement of apoptosis (PMID: 12917690). Despite its recognized tumor suppressor role, CYLD also modulates microtubule dynamics and plays roles in cell migration and angiogenesis (PMID: 18222923, 20194890). CYLD is involved in other physiological processes, such as immune response, inflammation, cell cycle progression, spermatogenesis and osteoclastogenesis (PMID: 19373246). CYLD is mutated at low frequencies in various tumors. Around 25% of CYLD alterations are truncating mutations (cBioPortal, MSKCC, Jan. 2017). Germline mutations in CYLD gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome (PMID: 26370355, 20502185, 16307661, 26329847).",,2017-03-28,,1540,CYLD,CYLD lysine 63 deubiquitinase,False,ENST00000398568,NM_001042355.1,CYLDI,MFT1,SBS,EAC,CDMT,CYLD1,MFT,USPL2,TEM,BRSS,False,19373246,CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.,Cell death and differentiation,2018-01-01T20:10:00,17,True,25-34,0001-01-07,doi: 10.1038/cdd.2009.43,,0001-01-01,,26370355,Inherited cylindromas: lessons from a rare tumour.,The Lancet. Oncology,2018-09-01T20:15:00,16,9,e460-e469,Rajan N et al,doi: 10.1016/S1470-2045(15)00245-4,,0001-09-01,,12917691,The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.,Nature,2018-08-14T20:03:00,424,6950,801-5,Kovalenko A et al,,,0001-08-14,,12917690,Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.,Nature,2018-08-14T20:03:00,424,6950,797-801,Brummelkamp TR et al,,,2018-08-14T08:01:00,,18222923,The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration.,The Journal of biological chemistry,2018-04-04T20:08:00,283,14,8802-9,Gao J et al,doi: 10.1074/jbc.M708470200,,0001-04-04,,26329847,"Report of Three Novel Germline CYLD Mutations in Unrelated Patients with Brooke-Spiegler Syndrome, Including Classic Phenotype, Multiple Familial Trichoepitheliomas and Malignant Transformation.","Dermatology (Basel, Switzerland)",2016,232,True,30-7,Tantcheva-Poór I et al,doi: 10.1159/000437303,,"Tantcheva-Poór I et al. Dermatology (Basel, Switzerland). 2016;232(1)30-7.",,20502185,Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations: evidence of diverse somatic mutations in the same patient regardless of tumor type.,"Diagnostic molecular pathology : the American journal of surgical pathology, part B",2018-06-01T20:10:00,19,2,83-91,Sima R et al,doi: 10.1097/PDM.0b013e3181ba2d96,,0001-06-01,,20194890,CYLD regulates angiogenesis by mediating vascular endothelial cell migration.,Blood,2018-05-20T20:10:00,115,20,4130-7,Gao J et al,doi: 10.1182/blood-2009-10-248526,,0001-05-20,,16307661,Two novel CYLD gene mutations in Chinese families with trichoepithelioma and a literature review of 16 families with trichoepithelioma reported in China.,The British journal of dermatology,2017-12-01T20:05:00,153,6,1213-5,Liang YH et al,,,0001-12-01,,12917689,CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.,Nature,2018-08-14T20:03:00,424,6950,793-6,Trompouki E et al,,,0001-08-14,
19769,GENE_SUMMARY,,"CYLD, a negative regulator of NF-κB, is mutated at low frequencies in various cancers.",,2017-03-28,,1540,CYLD,CYLD lysine 63 deubiquitinase,False,ENST00000398568,NM_001042355.1,CYLDI,MFT1,SBS,EAC,CDMT,CYLD1,MFT,USPL2,TEM,BRSS,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
